Report
Peter Thilo Hasler

Zweistellige Preiserhöhungen durchgesetzt

Bislang ist es Alzchem gut gelungen, die signifikanten Rohstoff- und Energiepreiserhöhungen auf die Kunden überzuwälzen – auch wenn dies nur zeitverzögert möglich war. Ungeachtet dessen lag das operative Ergebnis im ersten Quartal 2022 leicht unter unseren Erwartungen. Hohe Auftragsbestände lassen aus unserer Sicht erwarten, dass sich die Kostenweitergabe im Jahresverlauf beschleunigen wird, so dass wir, in Verbindung mit fortgesetzten Prozesskostenoptimierungen, unsere Umsatz- und Ergebnisprognosen für erreichbar halten. Wir bestätigen unser aus einem dreiphasigen DCF-Entity-Modell ermitteltes Kursziel von EUR 35,20 (Base-Case-Szenario) und unser Buy-Rating für die Aktien der Alzchem Group AG.

Underlying
AlzChem Group

AlzChem Group AG, formerly Softmatic AG, is a Germany-based group parent company for a vertically integrated producer of chemical products based on the calcium carbide/calcium cyanamide chain. The Group's operating business is divided into three segments: Specialty Chemicals, Basics & Intermediates and Other & Holding. Its products can be applied in areas, such as nutrition, renewable energy, fine chemicals, agriculture and metallurgy. The Company produces dietary supplements; epoxy resin hardeners for use in adhesives, powder coatings, printed circuit boards and composites; silicon nitride for advanced ceramics and solar wafers; technical gases; specialty fertilizer, germicide for use in pig pens, plant growth regulators and plant protection additives, among others. It also provides related services. The Company operates production sites in Germany and Sweden, a sales subsidiary in the United States and a Chinese subsidiary for the purchase of raw materials and distribution in Asia.

Provider
Sphene Capital GmbH
Sphene Capital GmbH

Founded in 2010, Sphene Capital is a German based pure-play research house offering state-of-the-art research and evaluation services to European small- and mid-caps by avoiding typical conflict of interests of traditional investment banks.

As a general rule, analysts of Sphene Capital strive to understand companies better than any other analyst or investor before publishing their initiation reports. Therefore, the comprehensive initiation research reports comprise of 50-80 pages, including an extensive analysis of the value chain of the IPO candidate, its unique selling proposition, an elaborate analysis of suppliers and clients, a thorough SWOT analysis, a commercial due diligence (i. e. market and competitive analysis), an integrated financial forecast model and a profound company valuation (both DCF methodology and peer group multiples). Before publication, each of Sphene Capital’s research report will be double-checked by a fellow research colleague (“Four-eyes-principle”), ensuring highest quality and avoiding careless mistakes.

After initiation of research coverage, Sphene Capital publishes regular updates of 12-30 pages following relevant news flow from the issuer or major peers, f. ex. after acquisitions or after publication of quarterly results.

Due to Sphene Capital’s extensive experience in equity and bond research, the team has established longstanding contacts to all relevant market players, i. e. institutional investors, family offices and high net-worth individuals as well as journalists. To each of these groups, Sphene Capital’s research analysts have regular contacts during analyst and management roadshows or via daily phone calls. Finally, analysts publish articles in selected stock markets magazines and websites in which the analysts help issuers to improve their popularity on the German capital markets.

Analysts
Peter Thilo Hasler

Other Reports on these Companies
Other Reports from Sphene Capital GmbH

ResearchPool Subscriptions

Get the most out of your insights

Get in touch